Stemina uses metabolomic technologies to study biology and disease in market areas important to human health. NeuropointDX, Stemina's diagnostic division, is developing a diagnostic platform using human patient samples to understand the metabolic mechanisms involved in health and diseases such as cancer, autism and others. The company's Children's Autism Metabolome Project (CAMP), is the largest metabolomics study of autistic children ever conducted. This ongoing study is designed to discover biomarkers and develop assays for the early diagnosis of autism using patient samples. Stemina's also uses pioneering cell based assays arise from the strategic convergence of the groundbreaking technologies metabolomics and human embryonic stem cells. In addition, Stemina provides drug screening, drug discovery and diagnostic development services for pharmaceutical and biotechnology companies under service contracts or joint discovery agreements using its proprietary metabolomics platform.
Link up your social media account to automatically promote the positions at Stemina Biomarker Discovery, Inc..
Get a job alert every time Stemina Biomarker Discovery, Inc. posts a job.
Stemina is seeking a motivated individual interested in a career in bioinformatics and software engineering. This position is an opportunity to develop technical bioinformatics skills. In this position you will be expected to help implement, maintain and3/7/2017 Madison, WI Save This Job
Department: Bio-Analytical Technologies Location: Madison, WI Reports To: COO and VP of R & D FLSA Status: Exempt Entities Served: Stemina Biomarker Discovery Direct Reports: 3-6 Company Description Stemina Biomarker Discovery and its NeuropointDX division are pioneering the use2/1/2017 Madison, WI Save This Job